By Mandy Jackson
Daily Journal Staff Writer
The Centers for Medicare and Medicaid Services proposed a new rule on Wednesday that would require manufacturers of drugs and medical devices paid for by the federal and state health care programs to report all payments or other transfers of value they make to doctors and hospitals.
The companies also would have to report to CMS any physician ownership or investment interests in their businesses. The rule is required under ...
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!
Or access this article for $45
(Purchase provides 7-day access to this article. Printing, posting or downloading is not allowed.)
Already a subscriber?
Sign In